Mesothelioma Tumor Reactions Inform Potential Treatments
Australian Researchers Discover How Malignant Mesothelioma Tumors React. Researchers have discovered an unusual way in which asbestos-related tumors grow, which may help future treatment of asbestos-related diseases. Scientists at Adelaide's Flinders University in Australia found that malignant mesothelioma tumors transform into … [Read more...] about Mesothelioma Tumor Reactions Inform Potential Treatments
Doctors Reminded of Victoza Thyroid Tumor, Pancreatitis Risks
It seems many doctors are unaware of the serious side effects that may be associated with the Type II Diabetes drug Victoza. As a result, Novo Nordisk has sent a letter to doctors reminding them that Victoza may be associated with thyroid tumors and acute pancreatitis. Victoza is very similar to Byetta. Both are injectables, and … [Read more...] about Doctors Reminded of Victoza Thyroid Tumor, Pancreatitis Risks
Tests Predict if Procrit, Aranesp or Epogen Will Speed Tumor Growth
Study Says Genetic Tests May Predict if Procrit. Some cancer patients treated with the anemia drugs Procrit, Aranesp and Epogen could experience increased tumor growth. However, researcher recently reported that there may be a way to predict which cancer patients are at risk for this devastating side effect. Procrit, Aranesp and … [Read more...] about Tests Predict if Procrit, Aranesp or Epogen Will Speed Tumor Growth
Aranesp Study Shows Little Benefit for Breast Cancer Patients
Aranesp, an anemia drug, does not appear to benefit breast cancer patients. Amgen Inc., maker of Aranesp, recently said interim results from an independent study involving breast cancer patients found Aranesp did not enhance the effect of chemotherapy prior to surgery. The study involved over 700 patients and evaluated whether … [Read more...] about Aranesp Study Shows Little Benefit for Breast Cancer Patients
